Business Context and Reporting Period
Company: Progyny, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 18, 2020
Reporting Period: Single event date (March 18, 2020)
Business Context: The filing serves as a Regulation FD disclosure to provide an update on the impact of the COVID-19 pandemic on the Company's operations.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a press release regarding operational impacts rather than a financial statement.
Material Changes
The primary material change disclosed is the operational impact of the COVID-19 pandemic. The Company issued a press release (Exhibit 99.1) detailing these impacts, which is incorporated by reference into this filing.
Guidance, Outlook, and Risks
- Management Commentary: The Company provided an update on the impact of COVID-19 via a press release dated March 18, 2020.
- Risks and Contingencies: The filing highlights the risk associated with the ongoing COVID-19 pandemic, though specific quantitative risks are contained within the referenced press release.
- Legal Disclaimer: The information furnished under Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any other SEC filing.
Investor Verification Checklist
- Review the full text of the press release dated March 18, 2020 (Exhibit 99.1) for specific details on operational disruptions.
- Verify if subsequent filings provide quantitative financial impacts resulting from the COVID-19 pandemic.
- Note that this specific 8-K filing does not contain audited or unaudited financial data.